Dr. Nathan Pennell started his medical career at the University of Florida College of Medicine in Gainesville and completed his residency in medical oncology at the Brigham & Women’s Hospital, one of the leading mesothelioma research centers in the United States. Dr. Pennell finished a fellowship at the Dana-Farber Cancer Institute Harvard Medical School in 2007. Dr. Pennell currently practices at the Cleveland Clinic’s Taussig Cancer Institute as the Director of the lung cancer medical oncology program and specializes in clinical trials for mesothelioma and other lung cancers. Numerous research grants and awards recommend Dr. Pennell as one of the country’s leading young mesothelioma doctors.
University Of Florida Graduated in 2002
Brigham and Womens Hospital Completed in 2003
Brigham and Womens Hospital Completed in 2005
Dana-Farber Cancer Institute Completed in 2007
American Board of Internal Medicine - Oncology
Abbas, H.,Karimianpour, A.,Pennell, N. A.; Am. J. Med. SciSee more >>
Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung Cancer.
Halmos, B.,Pennell, N. A.,Fu, P.,Saad, S.,Gadgeel, S.,Otterson, G. A.,Mekhail, T.,Snell, M.,Kuebler, J. P.,Sharma, N.,Dowlati, A.; OncolSee more >>
EGFR molecular testing in African-American non-small cell lung cancer patients - a review of discrepant data.
Clifford BT Fu P Pennell NA Halmos B Leidner RS; Transl Lung Cancer ResSee more >>
American Society of Clinical Oncology